-
公开(公告)号:US20230021476A1
公开(公告)日:2023-01-26
申请号:US17835559
申请日:2022-06-08
Applicant: ARCUS BIOSCIENCES, INC.
Inventor: Joel Worley BEATTY , Samuel Lawrie DREW , Matthew EPPLIN , Jeremy Thomas Andre FOURNIER , Balint GAL , Tezcan GUNEY , Karl T. HAELSIG , Clayton HARDMAN , Steven Donald JACOB , Jenna Leigh JEFFREY , Jaroslaw KALISIAK , Kenneth Victor LAWSON , Manmohan Reddy LELETI , Erick Allen LINDSEY , Artur Karenovich MAILYAN , Debashis MANDAL , Guillaume MATA , Hyunyoung MOON , Jay Patrick POWERS , Brandon Reid ROSEN , Yongli SU , Anh Thu TRAN , Zhang WANG , Xuelei YAN , Kai YU
IPC: C07C317/32 , A61K31/10 , A61K31/277 , A61K31/343 , A61K31/353 , A61K31/365 , A61K31/381 , A61K31/404 , A61K31/415 , A61K31/416 , A61K31/4174 , A61K31/4192 , A61K31/4196 , A61K31/421 , A61K31/423 , A61K31/426 , A61K31/428 , A61K31/437 , A61K31/44 , A61K31/4412 , A61K31/47 , A61K31/4709 , A61K31/472 , A61K31/4965 , A61K31/50 , A61K31/5025 , A61K31/505 , A61K31/519 , A61K31/538 , A61K39/395 , A61K45/06 , C07C255/53 , C07C317/22 , C07C317/36 , C07D209/34 , C07D211/86 , C07D213/57 , C07D213/71 , C07D213/73 , C07D213/74 , C07D213/84 , C07D215/48 , C07D217/04 , C07D231/12 , C07D231/56 , C07D233/64 , C07D237/20 , C07D239/42 , C07D241/12 , C07D249/06 , C07D249/08 , C07D263/32 , C07D263/57 , C07D265/36 , C07D277/30 , C07D277/56 , C07D277/64 , C07D307/83 , C07D311/22 , C07D333/64 , C07D401/04 , C07D401/10 , C07D409/10 , C07D413/10 , C07D471/04 , C07D487/04
Abstract: Compounds that inhibit HIF-2α, and compositions containing the compound(s) and methods for synthesizing the compounds, are described herein. Also described are the use of such compounds and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by HIF-2α.
-
公开(公告)号:US20240254079A1
公开(公告)日:2024-08-01
申请号:US18239892
申请日:2023-08-30
Applicant: ARCUS BIOSCIENCES, INC.
Inventor: Joel Worley BEATTY , Samuel Lawrie DREW , Matthew EPPLIN , Jeremy Thomas Andre FOURNIER , Balint GAL , Tezcan GUNEY , Karl T. HAELSIG , Clayton HARDMAN , Steven Donald JACOB , Jenna Leigh JEFFREY , Jaroslaw KALISIAK , Kenneth Victor LAWSON , Manmohan Reddy LELETI , Erick Allen LINDSEY , Artur Karenovich MAILYAN , Debashis MANDAL , Guillaume MATA , Hyunyoung MOON , Jay Patrick POWERS , Brandon Reid ROSEN , Yongli SU , Anh Thu TRAN , Zhang WANG , Xuelei YAN , Kai YU
IPC: C07C317/32 , A61K31/10 , A61K31/277 , A61K31/343 , A61K31/353 , A61K31/365 , A61K31/381 , A61K31/404 , A61K31/415 , A61K31/416 , A61K31/4174 , A61K31/4192 , A61K31/4196 , A61K31/421 , A61K31/423 , A61K31/426 , A61K31/428 , A61K31/437 , A61K31/44 , A61K31/4412 , A61K31/47 , A61K31/4709 , A61K31/472 , A61K31/4965 , A61K31/50 , A61K31/5025 , A61K31/505 , A61K31/519 , A61K31/538 , A61K39/395 , A61K45/06 , C07C255/53 , C07C317/22 , C07C317/36 , C07D209/34 , C07D211/86 , C07D213/57 , C07D213/71 , C07D213/73 , C07D213/74 , C07D213/84 , C07D215/48 , C07D217/04 , C07D231/12 , C07D231/56 , C07D233/64 , C07D237/20 , C07D239/42 , C07D241/12 , C07D249/06 , C07D249/08 , C07D263/32 , C07D263/57 , C07D265/36 , C07D277/30 , C07D277/56 , C07D277/64 , C07D307/83 , C07D311/22 , C07D333/64 , C07D401/04 , C07D401/10 , C07D409/10 , C07D413/10 , C07D471/04 , C07D487/04
CPC classification number: C07C317/32 , A61K31/10 , A61K31/277 , A61K31/343 , A61K31/353 , A61K31/365 , A61K31/381 , A61K31/404 , A61K31/415 , A61K31/416 , A61K31/4174 , A61K31/4192 , A61K31/4196 , A61K31/421 , A61K31/423 , A61K31/426 , A61K31/428 , A61K31/437 , A61K31/44 , A61K31/4412 , A61K31/47 , A61K31/4709 , A61K31/472 , A61K31/4965 , A61K31/50 , A61K31/5025 , A61K31/505 , A61K31/519 , A61K31/538 , A61K39/3955 , A61K45/06 , C07C255/53 , C07C317/22 , C07C317/36 , C07D209/34 , C07D211/86 , C07D213/57 , C07D213/71 , C07D213/73 , C07D213/74 , C07D213/84 , C07D215/48 , C07D217/04 , C07D231/12 , C07D231/56 , C07D233/64 , C07D237/20 , C07D239/42 , C07D241/12 , C07D249/06 , C07D249/08 , C07D263/32 , C07D263/57 , C07D265/36 , C07D277/30 , C07D277/56 , C07D277/64 , C07D307/83 , C07D311/22 , C07D333/64 , C07D401/04 , C07D401/10 , C07D409/10 , C07D413/10 , C07D471/04 , C07D487/04 , C07C2602/08 , C07C2602/10
Abstract: Compounds that inhibit HIF-2α, and compositions containing the compound(s) and methods for synthesizing the compounds, are described herein. Also described are the use of such compounds and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by HIF-2α.
-
公开(公告)号:US20230159466A1
公开(公告)日:2023-05-25
申请号:US18050557
申请日:2022-10-28
Applicant: ARCUS BIOSCIENCES, INC.
Inventor: Joel Worley BEATTY , Samuel Lawrie DREW , Matthew EPPLIN , Jeremy FOURNIER , Balint GAL , Clayton HARDMAN , Artur Karenovich MAILYAN , Kenneth Victor LAWSON , Manmohan Reddy LELETI , Dongdong LIU , Guillaume MATA , Masa PODUNAVAC , Jay Patrick POWERS , Brandon Reid ROSEN , Kai YU
IPC: C07D231/56 , C07D413/06 , C07D405/06 , C07D409/06 , C07D405/04 , C07D409/04
CPC classification number: C07D231/56 , C07D413/06 , C07D405/06 , C07D409/06 , C07D405/04 , C07D409/04
Abstract: The present disclosure is directed to compounds that are inhibitors of HIF-2α having a structure according to Formula I, and compositions containing those compounds. Methods of using the compounds for the treatment of diseases, disorders, or conditions are also described.
-
公开(公告)号:US20210317079A1
公开(公告)日:2021-10-14
申请号:US17205273
申请日:2021-03-18
Applicant: ARCUS BIOSCIENCES, INC.
Inventor: Joel Worley BEATTY , Samuel Lawrie DREW , Matthew EPPLIN , Jeremy Thomas Andre FOURNIER , Balint GAL , Tezcan GUNEY , Karl T. HAELSIG , Clayton HARDMAN , Steven Donald JACOB , Jenna Leigh JEFFREY , Jaroslaw KALISIAK , Kenneth Victor LAWSON , Manmohan Reddy LELETI , Erick Allen LINDSEY , Artur Karenovich MAILYAN , Debashis MANDAL , Guillaume MATA , Hyunyoung MOON , Jay Patrick POWERS , Brandon Reid ROSEN , Yongli SU , Anh Thu TRAN , Zhang WANG , Xuelei YAN , Kai YU
IPC: C07C317/32 , A61K45/06 , C07C317/22 , C07D311/22 , C07D215/48 , C07D401/04 , A61K31/277 , A61K31/10 , A61K31/353 , A61K31/47 , A61K31/4709 , A61K31/538 , C07D265/36 , C07D217/04 , A61K31/472 , C07D413/10 , C07D409/10 , C07D401/10 , C07D333/64 , A61K31/381 , A61K31/343 , C07D307/83 , C07D231/12 , C07C255/53 , C07D213/57 , A61K31/44 , A61K31/365 , A61K31/415 , A61K31/4192 , C07D249/06 , C07D263/32 , A61K31/421 , C07D213/84 , C07D213/73 , C07D277/30 , A61K31/426 , A61K31/4412 , C07D211/86 , C07D209/34 , A61K31/404 , A61K31/505 , C07D239/42 , C07D249/08 , A61K31/4196 , A61K31/4965 , C07D241/12 , C07D237/20 , A61K31/50 , C07D277/56 , C07D231/56 , A61K31/416 , A61K31/428 , C07D277/64 , C07D213/71 , C07D213/74 , C07D233/64 , A61K31/4174 , C07C317/36 , C07D263/57 , A61K31/423 , C07D471/04 , A61K31/437 , C07D487/04 , A61K31/519 , A61K31/5025 , A61K39/395
Abstract: Compounds that inhibit HIF-2α, and compositions containing the compound(s) and methods for synthesizing the compounds, are described herein. Also described are the use of such compounds and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by HIF-2α.
-
-
-